Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss*t
|
|
- Alexandra Garrison
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY Copyright" 1993 The American Fertility Society Vol. 50, No.5, November 1993 Printed on acid-free paper in U. S. A. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss*t Maurice G. A. J. Wouters, M.D.:!: Godfried H. J. Boers, M.D.II Henk J. Blom, Ph.D.~ Frans J. M. Trijbels, Ph.D.~ Chris M. G. Thomas, Ph.D.:!: George F. Borm, Ph.D.** Regine P. M. Steegers-Theunissen, M.D.:!: Tom K. A. B. Eskes, M.D.:!: University Hospital Nijmegen St Radboud, Nijmegen, The Netherlands Objective: To establish the prevalence of hyperhomocysteinemia in women with unexplained recurrent.early pregnancy loss. Design: In a patient-control study, the methionine-homocysteine metabolism was investigated by a standardized oral methionine-loading test. Setting: Gynecologic outpatient department of university hospital. Patients: One-hundred and two women who had been referred to the hospital because they suffered from at least two consecutive unexplained spontaneous abortions (study group) as well as 41 controls who were recruited by public advertisement were selected. Interventions: Blood samples were collected just before and 6 hours after oral methionine administration to determine plasma total homocysteine concentrations. Main Outcome Measure: Plasma total homocysteine concentrations 6 hours after methionine loading. Hyperhomocysteinemia was defined as total homocysteine concentration at 6 hours exceeding the 97.5 percentile level of the controls. Results: Hyperhomocysteinemia was diagnosed in 21 women of the study group (21%). In the parous women of the study group, the prevalence of hyperhomocysteinemia was more than two times greater compared with the nulliparous subjects (33% and 14%, respectively). Conclusion: Hyperhomocysteinemia is a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-5 Key Words: Homocysteine, habitual abortion, folate, vitamin B12 Recurrent early pregnancy loss is an intriguing problem in obstetric practice. Over the last decade, Received May 11, 1993; revised and accepted July 26, * Supported by grant number from Praeventiefonds, The Hague, The Netherlands. t Presented at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada, March 31 to April 3,1993. :j: Department of Obstetrics and Gynecology, University Hospital Nijmegen St Radboud. Reprint requests: Maurice G. A. J. Wouters, M.D., Department of Obstetrics and Gynecology, University Hospital Nijmegen St Radboud, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. II Department of Medicine, University Hospital Nijmegen St Radboud. many etiologic factors and several treatment regimens have been reported. However, there is little evidence for most causes of recurrent miscarriage and therapeutic interventions of any kind can be considered as merely empirical (1). Recently, we have presented preliminary data on hyperhomocysteinemia as a possible risk factor in women with recurrent spontaneous abortion or placental abruption (2). The present study reports the 1"[ Department of Pediatrics, University Hospital Nijmegen St Radboud. ** Department of Medical Statistics, University Hospital Nijmegen St Radboud. 820 Wouters et al. Homocysteine and habitual abortion Fertility and Sterility
2 ~I METHIONINE S-ADENOSYLMETHIONINE 1 BETAINE TETRAlY:ROFOLATE TETRAHYDROFOLATE METHYLENE- 5-METHYL TETRAHYDROFOLATE ~-synthase deficiency, is also associated with an increased risk of premature vascular disease (6-10). Methionine-homocysteine metabolism was investigated in 102 women with unexplained recurrent early pregnancy failure and in 41 controls to establish the prevalence of hyperhomocysteinemia. MATERIALS AND METHODS CYSTATHIONINE PYRIDOXAL-5-PHOSPHATE CYSTEINE Figure 1 Simplified scheme of the methionine-homocysteine metabolism and enzymes and vitamins involved. (1) Cystathionine {3-synthase; (2) 5-methyltetrahydrofolate-homocysteine methyltransferase (methionine synthase); (3) 5,1O-methylenetetrahydrofolate reductase. results of our extended investigation in women with at least two consecutive unexplained early pregnancy losses. Homocysteine is the demethylated derivative of the essential amino acid methionine. It is either irreversibly trans-sulphurated via cystathionine into cysteine, in which the first reaction is catalyzed by a pyridoxal-5-phosphate-(plp, a form of vitamin B6) dependent enzyme (cystathionine ~-synthase), or it is remethylated to methionine by either of two reactions. One of these reactions is dependent on folate and vitamin B12 (Fig. 1) (3). Homocystinuria due to cystathionine ~-synthase deficiency is an inborn error of metabolism with autosomal recessive inheritance and is characterized by massive urinary excretion of homocysteine and severe elevation of blood homocysteine and methionine (4). Premature arteriosclerosis and thromboembolism are life-threatening complications of homo cystinuria. This is explained by homocysteine-induced endothelial cell injury, which may initiate the development of typical arteriosclerotic lesions (5). Notably, fetal loss has been observed in 25 of 52 pregnancies of untreated homozygous cystathionine ~-synthase-deficient women, but these data were strongly influenced by the high number of stillbirths and spontaneous abortions in a few individuals (4). Several studies have demonstrated that hyperhomocysteinemia, in which the mildly elevated blood homocysteine concentrations are comparable to those in obligate heterozygosity for cystathionine Subjects Spontaneous abortion was defined as early pregnancy loss within 16 weeks of menstrual age, not including ectopic pregnancy and elective abortion. We studied 102 women (aged from 22 to 47 years) who had been referred to our hospital because they suffered from at least two consecutive unexplained spontaneous abortions (range 2 to 10) after conceiving from the same partner (study group). Seventy-seven subjects (75%) had three consecutive miscarriages or more. In total, all women (n = 102) experienced 378 spontaneous abortions. Sixtythree percent of all early pregnancy losses (n = 238) were histologically confirmed. In the remaining 37% (n = 140), pregnancy was diagnosed by a positive routine urinary heg test (>50 IU/L) and/or ultrasound imaging of at least one intrauterine gestational sac, with or without positive heartbeat. Thirty-six women (35%) had experienced one or more pregnancies (range 1 to 4) that had developed past 16 weeks amenorrhea. In all women of the study group, chromosomal rearrangements, severe uterine anomalies, and immunologic disorders were excluded by routine investigation procedures. These consisted of parental chromosome karyotyping, uterine evaluation by either hysterosalpingogram and/or hysteroscopy (84% of cases), or ultrasound alone, and tests for both anticardiolipin antibodies (standardized ELISA) and lupus anticoagulant (kaolin clotting time, 1:5 dilution of patients' samples in phospholipid-free substrate plasma). As controls, we studied 41 women (aged 30 to 44 years) who had delivered at least one live child (range 1 to 4) and had not suffered from spontaneous abortion, fetal death, or placental abruption. They were recruited by public advertisement. All women of both the study and the control group (n = 143) were healthy and had not suffered from renal, liver, or vascular disease. Serum creatinine, range 0.6 to 1.0 mg/dl (52 to 91 ~mol/l), serum alanine aminotransferase, range 5 to 29 IU /L (0.08 to 0.48 ~mol/s per L), and serum aspartate Vol. 60, No.5, November 1993 Wouters et al. Homocysteine and habitual abortion 821
3 aminotransferase, range 4 to 21 IU/L (0.07 to 0.35 JLmol/s per L) were within the normal range. The study was approved by the Ethical Committee of the University Hospital Nijmegen St Radboud, Nijmegen, The Netherlands. Before participation, informed consent was obtained from all subjects. Investigation Procedure All women were instructed not to become pregnant before the investigation. They were not allowed to take oral contraceptives, hormonal and vitamin supplements, and other medication possibly interfering with methionine-homocysteine metabolism for at least 3 months before the study. Methionine-homocysteine metabolism was investigated by a standardized oral methionine-loading test. After an overnight fast, venous blood samples were drawn to measure the total homocysteine concentration in plasma at baseline and the concentrations of vitamins (PLP in whole blood, vitamin B12 in serum, and folate, both in serum and red cells). Then L-methionine, 0.1 g (0.7 mmol)/kg body wt, was administered orally in 200 ml of orange juice. All women used a standardized methionine-restricted breakfast and luncheon (total content of 14 mg methionine in 2 g protein, 95 g carbohydrate, and 31 g fat; total energy load of 2.8 kj). No drinks, except for coffee and tea without milk were allowed during the test period. Six hours after methionine loading, venous blood was collected for the measurement of the plasma total homocysteine concentration. To minimize possible hormonal influences on homocysteine metabolism, testing procedures were routinely arranged about 1 week before the expected first day of the next menstrual period (11). The majority of tests (73%) were performed within 6 months after completion of the last pregnancy. Hyperhomocysteinemia was diagnosed if total homocysteine concentration at 6 hours exceeded the 97.5 percentile level of the controls, independent of total homocysteine concentration at baseline and the fasting concentrations of PLP, vitamin B12, and folate. Sample Preparation and Analysis Blood samples for measurements of total homocysteine concentrations in plasma were drawn in ethylenediamine tetra-acetate vacutainer tubes of 4 ml and centrifuged within 30 minutes at 3,000 X g for 10 minutes. The plasma was separated and immediately stored at -20 C. Total homocysteine concentrations were measured by high-perfor- mance liquid chromatography (HPLC) technique and fluorometric detection (detection limit, 0.5 JLmol/L; intra-assay and interassay coefficients of variation, both < 5 %), according to Fiskerstrand et a1. (12). Dry and heparinized vacutainer tubes of 10 ml were used for collecting venous blood samples to assay PLP (whole blood), vitamin B12 (serum), and folate (serum and red cells) concentrations. Determination of PLP was performed by HPLC technique (11). Vitamin B12 and folate concentrations were measured simultaneously with Dualcount SPB (solid phase boil) Radioassay (Diagnostic Products Corporation, Los Angeles, CA), as previously described (13). Statistical Analysis Results are given as means ± SD. In assessing statistical significance, the Wilcoxon rank sum test and Spearman's rank correlation were used. P values were two tailed, and P < 0.05 was considered significant. RESULTS Total homocysteine concentration at baseline in the control group ranged from 6 to 19 JLmol/L whereas in women of the study group it ranged from 3 to 81 JLmol/L. The mean levels of total homocysteine concentration at baseline were significantly different between both groups (Table 1). In the control women, total homocysteine concentration at 6 hours ranged from 20 to 55 JLmol/L (Fig. 2), and the 97.5 percentile level of total homocysteine concentration at 6 hours was calculated as 51 JLmol/L. In the study group, total homocysteine concentration at 6 hours varied from 19 to 116 JLmol/L (Fig. 2). Mean total homocysteine concentration at 6 hours ofthe control and the study group were significantly different (Table 1). Hyperhomocysteinemia, i.e., total homocysteine concentration at 6 hours> 51 JLmol/L, was diagnosed in 21 of 102 women (21 %) with unexplained recurrent early pregnancy loss. The mean concentrations of serum vitamin B12, serum folate, and red cell folate were not significantly different between the control and the study group (Table 1). Severe cobalamin deficiency, i.e., serum vitamin B12 < 100 pmol/l, was found in six women of the study group, four of whom were hyperhomocysteinemic, but not in the controls. Low serum folate, i.e., 4 to 6 nmol/l, was detected in three hyperhomocysteinemic women (one of whom 822 Wouters et al. Homocysteine and habitual abortion Fertility and Sterility
4 Table 1 Concentrations of Plasma Total Homocysteine and Blood Vitamins in the Control and the Study Group* Total homocysteine concentration at baseline, plasma (ILmol/L) Total homocysteine concentration at 6 hr, plasma (ILmol/L) PLP, whole blood (nmol/l) Vitamin B12, serum (pmol/l) Folate, serum (nmol/l) Folate, red cells (nmol/l) Control group Study group (n = 41) (n = 102) 10 ± 3 31 ± 9 51 ± ± ± ± ± lot 42 ± 19t 46 ± 18t 261 ± ± ± 302 * Values are means ± SD. t Statistically significant difference (P < 0.05) compared with the control group. was also severely cobalamin deficient) and in two normohomocysteinemic subjects of the study group but in none of the controls. Severe cobalamin deficiency' low serum folate, and low red cell folate concentrations were simultaneously present in one hyperhomocysteinemic woman of the study group (serum vitamin B12, 84 pmol/l; serum folate, 4.8 nmol/l; red cell folate, 170 nmol/l; and total homocysteine concentration at 6 hours, 83 ~mol/l). The mean concentration of PLP was significantly lower in the women of the study group as compared with the controls (Table 1). However, PLP was normal in all subjects of the study group and in all controls. In the control group, only serum folate was negatively and significantly correlated to both total homocysteine concentration at baseline (r = -0.4) and total homocysteine concentration at 6 hours (r = -0.5). In the study group, serum and red cell folate were negatively and significantly correlated with total homocysteine concentration at baseline (r = -0.3 and -0.4, respectively), and total homocysteine concentration at 6 hours (r = -0.4 and -0.3, respectively), whereas serum vitamin B12 was negatively and significantly correlated to total homocysteine concentration at baseline (r = -0.5), but not to total homocysteine concentration at 6 hours. Neither the number of spontaneous abortions nor the mean gestational age at which pregnancy losses occurred were significantly correlated to total homocysteine concentration at 6 hours. In the parous women of the study group, mean total homocysteine concentration at 6 hours was significantly higher compared with the nulliparous subjects (48 ± 21 versus 38 ± 16 ~mol/l; means ± SD). Hyperhomocysteinemia was found in 12 of 36 (33%) parous and in 9 of 66 (14%) nulliparous women of the study group. The means of total homocysteine concentration at baseline and all studied vitamins, however, did not differ significantly between these subgroups (data not shown). Two parous women, in whom hyperhomocysteinemia was identified, had received vitamin B supplements with five previous pregnancies, but these had all aborted. DISCUSSION The main finding of the present study is the observation of hyperhomocysteinemia in 21 % of women with unexplained recurrent early pregnancy loss. This result confirms our preliminary report (2). The question arises by which pathogenetic mechanism elevated concentrations of plasma homocysteine may cause early pregnancy loss. There is convincing evidence that even mild elevation of THC-6 (J.Imol/l) I',.:. I u:: :n control group :i:, study group Figure 2 Individual total homocysteine concentration at 6 hours of all control women (n = 41) and of all women of the study group (n = 102). Vol. 60, No.5, November 1993 Wouters et al. Homocysteine and habitual abortion 823
5 blood homocysteine concentrations leads to premature vascular disease (6-10). One could speculate that increased levels of maternal plasma homocysteine may cause early damage of decidual or chori- 0nic vessels, leading to disturbed implantation of the conceptus. Recently, Meegdes et al. (14) provided histologic evidence of a higher prevalence of avascular villi and a decreased vascular density of vascularized villi in cases of spontaneous abortion compared with controls. On the other hand, maternal hyperhomocysteinemia may account for other toxic effects in some cases of early pregnancy loss. In this respect, specific embryotoxicity of L-homocysteine has recently been demonstrated in vitro (15). It is also interesting that neural tube defects (NTDs) have been identified in about 1 % of spontaneously aborted fetuses and that the development of NTD in the offspring has been associated with hyperhomocysteinemia in the mother (16, 17). The etiology of hyperhomocysteinemia in patients with premature vascular disease is still unknown but may be due to decreased cystathionine (j-synthase activity (6, 7). In the present study, cystathionine (j-synthase activity has not been investigated. In our preliminary study of hyperhomocysteinemia in women with recurrent spontaneous abortion, however, we have reported that the cystathionine (j-synthase activities, as determined in cultured fibroblasts from a skin biopsy, were within the normal range (2). These data suggest that hyperhomocysteinemia in these women is not caused by a blockade of the homocysteine trans-sulphuration pathway but is due to a defective remethylation of homocysteine into methionine. Malnutrition and malabsorption of folate and vitamin B12 or inherited enzyme defects involved in the metabolism of these vitamins, such as methylenetetrahydrofolate reductase deficiency (see Fig. 1), may also result in hyperhomocysteinemia (18, 19). In 1964, Hibbard (20) suggested a higher prevalence of defective folate metabolism in women with two or more consecutive abortions, compared with controls, as indicated by their excessive formiminoglutamic acid excretion after histidine loading. He has also measured lower serum and red cell folate levels in women with recurrent abortion compared with subjects with normal early pregnancies (Hibbard BM, abstract). In the present study, however, we observed no differences between women with unexplained recurrent early pregnancy loss and the controls with regard to the mean blood concentrations of vitamin B12 and folate. Nevertheless, severe cobalamin deficiency and low serum folate concentrations were detected in a small number of women of the study group (about 9%, the half of which was hyperhomocysteinemic) but in none of the controls. We cannot rule out the possibility that spontaneous abortion, at least in some cases, results from a primary nutritional deficit or metabolic derangement of vitamin B12 and/or folate, of which hyperhomocysteinemia is merely a concomitant finding. Apart from maternal hyperhomocysteinemia, inherited disorders of methionine-homocysteine metabolism of the conceptus itself may contribute to its death. Studies in trophoblast cells should provide data on this option. Remarkably, the prevalence of hyperhomocysteinemia in parous women of the study group was observed to be greater than two times that of nulliparous subjects. A negative association between folate metabolism and parity has been suggested in the literature (21). In the present study, however, we found no significant differences between the blood folate concentrations of parous and nulliparous women of the study group. At the moment, we have no explanation for this intriguing observation. Pyridoxine administration, with or without folic acid, has been shown to reduce plasma homocysteine in vascular patients with hyperhomocysteinemia (22, 23). According to our experience in nonpregnant hyperhomocysteinemic women, normohomocysteinemia may well be achieved by daily oral administration of only folic acid in a dose as low as 1 mg. The question remains whether biochemical normalization of hyperhomocysteinemia by periconceptional folate administration will favor the pregnancy outcome in women with unexplained recurrent miscarriage. A randomized double-blind prevention trial, which should provide the answer to this important question, is being initiated at our institute. In conclusion, hyperhomocysteinemia is a risk factor in women with unexplained recurrent early pregnancy loss. Spontaneous abortion may result from vascular-damaging effects of this condition. Acknowledgments. We thank all of the women who participated in the study. We also acknowledge the following individuals from University Hospital Nijmegen St Radboud, Nijmegen: Louis A. Schellekens, M. D. and Martijn F. G. Segers, B. S. for their critical and stimulating support; Marie-Therese E. C. Moorrees, M. D. and Nelleke J. Hamel-van Bruggen, research nurse, for their outstanding assistance in data collection; and technicians Ms. Maria T. W. B. te Poele-Pothoff and Mr. Loek 824 Wouters et al. Homocysteine and habitual abortion Fertility and Sterility
6 M. F. Geelen for their excellent assistance III laboratory analysis. REFERENCES 1. Stirrat GM. Recurrent miscarriage II: clinical associations, causes, and management. Lancet 1990; 336: Steegers-Theunissen RPM, Boers GHJ, Blom HJ, Trijbels JMF, Eskes TKAB. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae [letter]. Lancet 1992;339: Mudd SH, Levy HL. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989: Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine /'i-synthase deficiency. Am J Hum Genet 1985;37: Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteineinduced arteriosclerosis: the role of endothelial injury and platelet response in its genesis. J Clin Invest 1976;58: Boers G HJ, Smals AG H, Trijbels F JM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313: Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324: Kang S-S, Wong PWK, Malinow MR. Hyperhomocyst (e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992; 12: Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RB, ed. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992: Steegers-Theunissen RPM, Boers GHJ, Steegers EAP, Trijbels JMF, Thomas CMG, Eskes TKAB. Effects of sub- 50 oral contraceptives on homocysteine metabolism. Contraception 1992;45: Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols determined in plasma and urine: automation and sample stability. Clin Chern 1993; 39: Mooij PNM, Thomas CMG, Doesburg WH, Eskes TKAB. Multivitamin supplementation in oral contraceptive users. Contraception 1991;44: Meegdes BHLM, Ingenhoes R, Peeters LLH, Exalto N. Early pregnancy wastage: relationship between chorionic vascularization and embryonic development. Fertil Steril 1988;49: Aerts LAGJM van, Klaasboer HH, Postma NS, Pertijs JCLM, Copius Peereboom JHJ, Eskes TKAB, et al. Stereospecific in vitro embryotoxity of L-homocysteine in pre- and post-implantation rodent embryos. Toxicol In Vitro. In press. 16. Byrne J, Warburton D. Neural tube defects in spontaneous abortions. Am J Med Genet 1986;25: Steegers-Theunissen RPM, Boers GHJ, Trijbels JMF, Eskes TKAB. Neural-tube defects and derangement of homocysteine metabolism [letter]. N Engl J Med 1990;324: Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989: Fenton W A, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989: Hibbard BM. The role of folic acid in pregnancy - with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964; 71: Stone ML, Luhby AL, Feldman R, Gordon M, Cooperman JM. Folic acid metabolism in pregnancy. Am J Obstet Gynecol 1967; 99: Boers GHJ. The clinical usefulness of homocysteine determinations. In: Smith U, Eriksson S, Lindgarde S, eds. Genetic susceptibility to environmental factors - a challenge for public intervention. Stockholm: Almquist & Wiksell International, 1988: Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease - effects of pyridoxine and folic acid treatment. Atherosclerosis 1990;81: Vol. 60, No.5, November 1993 Wouters et al. Homocysteine and habitual abortion 825
Provided by the American Venous Forum: veinforum.org
CHAPTER 3 CLOTTING DISORDERS Original authors: Edith A. Nutescu, Jessica B. Michaud, Joseph A. Caprini, Louis W. Biegler, and Robert R. McCormick Abstracted by Kellie R. Brown Introduction The normal balance
More informationINTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia
INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs
More informationINTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia
INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs
More informationPrediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in * (MBChB, FICMS, CABOG) **Sawsan Talib Salman (MBChB, FICMS, CABOG) ***Huda Khaleel Ibrahim (MBChB) Abstract Background: - Although
More informationThrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003
Thrombophilia Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003 Thrombophilia Hereditary and acquired risk factors for thrombosis Venous thromboembolism Arterial thromboembolism
More informationRationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss
Rationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss Recurrent Pregnancy Loss The reason that an embryo may not implant successfully is either because there is something intrinsically
More informationDisclosure. Objectives 2/21/2016
Recurrent Pregnancy Loss: The myths, the controversies and the evidence Mamie McLean, MD Assistant Professor Reproductive Endocrinology and Infertility University of Alabama at Birmingham Disclosure I
More informationINITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
More informationWhat Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?
Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning A Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning Drugs to Prevent Abnormal Blood
More informationREPRODUCTIVE ENDOCRINOLOGY
FERTILITY AND STERILITY VOL. 82, NO. 5, NOVEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY
More informationLEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD
LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD 2 Outline Genetics 101: Basic Concepts and Myth Busting Inheritance Patterns
More informationPrenatal screening and diagnostic tests
Prenatal screening and diagnostic tests Contents Introduction 3 First trimester routine tests in the mother 3 Testing for health conditions in the baby 4 Why would you have a prenatal test? 6 What are
More informationBUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE
BUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE SUBJECT: Pregnancy Testing and Counseling Protocol P&P # APPROVED BY: EFFECTIVE DATE: Mark Lundberg MD Health Officer REVISION DATE: 2/20/2010 Phyllis
More informationArtificial insemination with donor sperm
Artificial insemination with donor sperm Ref. 123 / 2009 Reproductive Medicine Unit Servicio de Medicina de la Reproducción Gran Vía Carlos III 71-75 08028 Barcelona Tel. (+34) 93 227 47 00 Fax. (+34)
More informationEFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY
1 Nada Polyclinic, Po ega, Croatia 2 School of Medicine, University of Zagreb, Zagreb, Croatia Preliminary Communication Received: April 15, 2004 Accepted: June 16, 2004 EFFECT OF INCREASED TESTOSTERONE
More informationThe sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n
More informationNeural tube defects: open spina bifida (also called spina bifida cystica)
Screening Programmes Fetal Anomaly Neural tube defects: open spina bifida (also called spina bifida cystica) Information for health professionals Publication date: April 2012 Review date: April 2013 Version
More informationPreconception Clinical Care for Women Medical Conditions
Preconception Clinical Care for Women All women of reproductive age are candidates for preconception care; however, preconception care must be tailored to meet the needs of the individual. Given that preconception
More informationSummary of the risk management plan (RMP) for Ofev (nintedanib)
EMA/738120/2014 Summary of the risk management plan (RMP) for Ofev (nintedanib) This is a summary of the risk management plan (RMP) for Ofev, which details the measures to be taken in order to ensure that
More informationHyperhomocysteinaemia and Vitamin B12 Deficiency: The Long-Term Effects in Cardiovascular Disease
Original Research DOI: 10.1159/000093746 Received: August 24, 2005 Accepted after revision: April 25, 2006 Published online: June 6, 2006 Hyperhomocysteinaemia and Vitamin B12 Deficiency: The Long-Term
More informationConsent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)
Name of Patient: Name of Partner: We, the Patient and Partner (if applicable) named above, are each over the age of twenty-one (21) years. By our signatures below, I/we request and authorize the performance
More informationEhlers-Danlos Syndrome Fertility Issues. Objectives
Ehlers-Danlos Syndrome Fertility Issues Baltimore Inner Harbor Independence Day Brad Hurst, M.D. Professor Reproductive Endocrinology Carolinas Medical Center - Charlotte, North Carolina Objectives Determine
More informationREI Pearls: Pitfalls of Genetic Testing in Miscarriage
The Skinny: Genetic testing of miscarriage tissue is controversial and some people question if testing is helpful or not. This summary will: 1) outline the arguments for and against genetic testing; 2)
More informationBirth defects. Report by the Secretariat
EXECUTIVE BOARD EB126/10 126th Session 3 December 2009 Provisional agenda item 4.7 Birth defects Report by the Secretariat 1. In May 2009 the Executive Board at its 125th session considered an agenda item
More informationIn - Vitro Fertilization Handbook
In - Vitro Fertilization Handbook William F. Ziegler, D.O. Medical Director Scott Kratka, ELD, TS Embryology Laboratory Director Lauren F. Lucas, P.A.-C, M.S. Physician Assistant Frances Cerniak, R.N.
More informationGLUCOSE TOLERANCE (FOR DIABETESMELLITUS)- NON-PREGNANT ADULT/CHILDREN (Under 18 years old) (OGTT)
GLUCOSE TOLERANCE TESTING GESTATIONAL DIABETIC SCREEN (GDS2) GLUCOSE TOLERANCE (FOR DIABETESMELLITUS)- NON-PREGNANT ADULT/CHILDREN (Under 18 years old) (OGTT) GLUCOSE 2-HR POST-GLUCOSE LOAD (2HGPL)-SCREEN
More informationPrognosis of Very Large First-Trimester Hematomas
Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate
More informationGenetics and Pregnancy Loss
Genetics and Pregnancy Loss Dorothy Warburton Genetics and Development (in Pediatrics) Columbia University, New York Estimates of Pregnancy Loss from Conception 1000 fertilized eggs (27% are lost) 728
More informationUNIT 13 (OPTION) Genetic Abnormalities
Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty
More informationABSTRACT LABOR AND DELIVERY
ABSTRACT POLICY Prior to fetal viability, intentionally undertaking delivery of a fetus is the equivalent of abortion and is not permissible. After fetal viability has been reached, intentionally undertaking
More informationAssisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register
1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: gunbyj@mcmaster.ca Supported by the IVF Directors Group of
More informationLesbian Pregnancy: Donor Insemination
Lesbian Pregnancy: Donor Insemination (Based on an article originally published in the American Fertility Association 2010 National Fertility and Adoption Directory. Much of this information will also
More informationThe Rh Factor: How It Can Affect Your Pregnancy
The American College of Obstetricians and Gynecologists f AQ FREQUENTLY ASKED QUESTIONS FAQ027 PREGNANCY The Rh Factor: How It Can Affect Your Pregnancy What is the Rh factor? How does a person get the
More informationWhy your weight matters during pregnancy and after birth
Information for you Published in November 2011 (next review date: 2015) Why your weight matters during pregnancy and after birth Most women who are overweight have a straightforward pregnancy and birth
More informationReduced Ovarian Reserve Is there any hope for a bad egg?
Reduced Ovarian Reserve Is there any hope for a bad egg? Dr. Phil Boyle Galway Clinic, 19 th March 2014 For more information on Low AMH see www.napro.ie Anti Mullerian Hormone AMH levels are commonly measured
More informationFERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?
FERTILITY AND AGE Introduction Delaying pregnancy is a common choice for women in today's society. The number of women in their late 30s and 40s attempting pregnancy and having babies has increased in
More informationGP Guidance: Management of nutrition following bariatric surgery
GP Guidance: Management of nutrition following bariatric surgery Introduction Patients who are morbidly obese will have struggled with their weight for many years before going forward for bariatric surgery.
More informationCHLAMYDIA SCREENING IN WOMEN
CHLAMYDIA SCREENING IN WOMEN APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE What screening should be done? NCQA ACCEPTED CODES DOCUMENTATION
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin
PACKAGE LEAFLET: INFORMATION FOR THE USER VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution Cyanocobalamin Read all of this leaflet carefully before you start using this medicine because
More informationTeriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011).
Page 1 of 10 ANALYTE NAME AND STRUCTURE TERIFLUNOMIDE Teriflunomide TRADE NAME Aubagio CATEGORY Antimetabolite TEST CODE PURPOSE Therapeutic Drug Monitoring GENERAL RELEVANCY BACKGROUND sclerosis. The
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationPERINATAL NUTRITION. Nutrition during pregnancy and lactation. Nutrition during infancy.
PERINATAL NUTRITION Nutrition during pregnancy and lactation Nutrition during infancy. Rama Bhat, MD. Department of Pediatrics, University of Illinois Hospital Chicago, Illinois. Nutrition During Pregnancy
More informationReproductive System & Development: Practice Questions #1
Reproductive System & Development: Practice Questions #1 1. Which two glands in the diagram produce gametes? A. glands A and B B. glands B and E C. glands C and F D. glands E and F 2. Base your answer
More informationLiver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB
Liver Function Tests Dr Stephen Butler Paediatric Advance Trainee TDHB Introduction Case presentation What is the liver? Overview of tests used to measure liver function RJ 10 month old European girl
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PS Inj - Alimta Therapeutic Class: Antineoplastic Agents Therapeutic Sub-Class: Antifolates Client: PS Inj Approval Date: 8/2/2004 Revision Date: 12/5/2006 I. BENEFIT
More informationAssisted Reproductive Technologies at IGO
9339 Genesee Avenue, Suite 220 San Diego, CA 92121 858 455 7520 Assisted Reproductive Technologies at IGO Although IGO no longer operates an IVF laboratory or program as such, we work closely with area
More informationMETHODS OF VITAMIN ANALYSIS
METHODS OF VITAMIN ANALYSIS Specimen requirements; Fasting plasma or serum Lithium Heparin is the anticoagulant of choice for vitamins such as; thiamine, riboflavin, retinol, tocopherols & cholecalciferol
More informationUMBILICAL CORD BLOOD COLLECTION
UMBILICAL CORD BLOOD COLLECTION by Frances Verter, PhD Founder & Director, Parent's Guide to Cord Blood Foundation info@parentsguidecordblood.org and Kim Petrella, RN Department of Obstetrics and Gynecology
More informationTextbook: Chapter 12 pages 351-353, Chapter 13 pages 385-388
EXERCISE 11: BEDSIDE GLUCOSE TESTING Textbook: Chapter 12 pages 351-353, Chapter 13 pages 385-388 Skills: Objectives: 15 points 1. List the limitations of the bedside glucose test procedure. 2. State the
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationDarlene Langhoff St. Thomas More High Ron Gerrits MSOE
Darlene Langhoff St. Thomas More High Ron Gerrits MSOE Investigating the Scene DNA analysis The Findings Crime scene is set up (optional power point ) Tip: Set up crime scene and have students take photos
More informationFirst Trimester Screening for Down Syndrome
First Trimester Screening for Down Syndrome What is first trimester risk assessment for Down syndrome? First trimester screening for Down syndrome, also known as nuchal translucency screening, is a test
More informationWhat women can do to optimise their health during pregnancy and that of their baby Claire Roberts
Periconception Planning to Protect Pregnancy and Infant Health 2015 What women can do to optimise their health during pregnancy and that of their baby Claire Roberts Pregnancy Complications Preterm Birth
More informationGene Therapy and Genetic Counseling. Chapter 20
Gene Therapy and Genetic Counseling Chapter 20 What is Gene Therapy? Treating a disease by replacing, manipulating or supplementing a gene The act of changing an individual s DNA sequence to fix a non-functional
More informationVaccines in Pregnancy MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO
Vaccines in Pregnancy MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO 1 Objectives List vaccines that should be given either during pregnancy or immediately post-partum in
More informationNeural Tube Defects - NTDs
Neural Tube Defects - NTDs Introduction Neural tube defects are also known as NTDs. They happen when the spine and brain do not fully develop while the fetus is forming in the uterus. Worldwide, there
More informationSchool-age child 5-1 THE BLOOD
C A S E S T U D Y 5 : School-age child Adapted from Thomson Delmar Learning s Case Study Series: Pediatrics, by Bonita E. Broyles, RN, BSN, MA, PhD. Copyright 2006 Thomson Delmar Learning, Clifton Park,
More informationALTERNATIVE TREATMENT PLAN AND CONSENT FOR MEDICAL ABORTION WITH MIFEPREX (MIFEPRISTONE) AND MISOPROSTOL
ALTERNATIVE TREATMENT PLAN AND CONSENT FOR MEDICAL ABORTION WITH MIFEPREX (MIFEPRISTONE) AND MISOPROSTOL The FDA gave its approval status to Mifepristone in 1996 based on research up to that time. Extensive
More informationObstetric Cholestasis (itching liver disorder) Information for parents-to-be
Oxford University Hospitals NHS Trust Obstetric Cholestasis (itching liver disorder) Information for parents-to-be page 2 You have been given this leaflet because you have been diagnosed with (or are suspected
More informationVITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS
39 Chapter 3 VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS Maxine Briggs TABLE OF CONTENTS I. Review of the
More informationDietary Reference Intakes: Vitamins
Biotin Coenzyme in synthesis of fat, glycogen, and amino acids Liver and smaller b amounts in fruits and 6* meats 8* 12* 20* 2 of biotin in humans or animals were found. This does not mean biotin are limited,
More informationCrohn's disease and pregnancy.
Gut, 1984, 25, 52-56 Crohn's disease and pregnancy. R KHOSLA, C P WILLOUGHBY, AND D P JEWELL From the Gastroenterology Unit, Radcliffe Infirmary, Oxford SUMMARY Infertility and the outcome of pregnancy
More informationConsent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)
Consent to Perform Preimplantation Genetic Screening (PGS) using Array Comparative Genomic Hybridization (acgh ) or Next Generation Sequencing (NGS) Purpose The purpose of Preimplantation Genetic Screening
More informationPreimplantation Genetic Diagnosis. Evaluation for single gene disorders
Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of
More informationGuidance for Preconception Care of Women with Thyroid Disease
Before, Between & Beyond Pregnancy The National Preconception Curriculum and Resources Guide for Clinicians Guidance for Preconception Care of Women with Thyroid Disease Avi Alkalay, MD Department of Obstetrics
More informationSummary of the risk management plan (RMP) for Cerdelga (eliglustat)
EMA/743948/2014 Summary of the risk management plan (RMP) for Cerdelga (eliglustat) This is a summary of the risk management plan (RMP) for Cerdelga, which details the measures to be taken in order to
More informationLecture 12a: Complications of Pregnancy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationCarol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota The information provided by speakers in workshops, forums, sharing/networking
More informationBREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt
Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years
More informationInsulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
More informationDiabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
More informationGESTATIONAL DIABETES. Diabete Gestazionale (Lingua Inglese)
GESTATIONAL DIABETES Diabete Gestazionale (Lingua Inglese) CONTENTS DEFINITION 03 WHAT CAUSES AND HOW TO MANAGE GESTATIONAL DIABETES 04 HOW TO CONTROL DIABETES 06 CORRECT LIFESTYLE 08 DURING AND AFTER
More informationHepatitis C. Laboratory Tests and Hepatitis C
Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what
More informationMethyl groups, like vitamins, are
Methyl groups are essential for the body to function properly and must be obtained from the diet The need for methyl groups increases under stress Chapter 11 Betaine a new B vitamin Methyl groups reduce
More informationAppendices. 2006 Bexar County Community Health Assessment Appendices Appendix A 125
Appendices Appendix A Recent reports suggest that the number of mothers seeking dropped precipitously between 2004 and 2005. Tables 1A and 1B, below, shows information since 1990. The trend has been that
More informationLondon Fertility Centre Price List
London Fertility Centre Price List Fertility Testing Packages Standard Female fertility testing package AMH Ultrasound scan 15 minute doctor consultation to discuss your results Premium Female fertility
More informationPatient & Family Guide Pre-Existing Diabetes and Pregnancy
Patient & Family Guide Pre-Existing Diabetes and Pregnancy Center for Perinatal Care Meriter Hospital 202 S. Park Street Madison, WI 53715 608.417.6667 meriter.com 09/12/1000 A Meriter Hospital and University
More informationFact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay. June 17, 2016
Dear Health Care Provider: Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay June 17, 2016 The U.S. Food and Drug Administration (FDA) has issued an Emergency
More informationInstitute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES
DATABASE REVIEW Grampian University Hospitals NHS Trust GRAMPIAN DIABETES SERVICES DATABASE Page 1 Contents Contents 2 Introduction 3 History 3 Overview of Database 3 Database Structure 4 Main Table Summary
More informationParvovirus B19 Infection in Pregnancy
Parvovirus B19 Infection in Pregnancy Information Pack Parvovirus B19 Infection in Pregnancy Information Booklet CONTENTS: THE VIRUS page 3 CLINICAL MANIFESTATIONS page 6 DIAGNOSIS page 8 PATIENT MANAGEMENT
More informationEffect of Riboflavin Status on the Homocysteine-lowering Effect of Folate in
Clinical Chemistry 49:2 295 302 (2003) Nutrition Effect of Riboflavin Status on the Homocysteine-lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype Stuart J. Moat, 1* Pauline A.L. Ashfield-Watt,
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationExecutive summary. Current prenatal screening
Executive summary Health Council of the Netherlands. NIPT: dynamics and ethics of prenatal screening. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/34. In recent years, new tests
More informationGestational diabetes mellitus (GDM) is defined
Prevalence of Gestational Diabetes Mellitus in a Medical College in South India: A Pilot Study K Sreekanthan*, A Belicita, K Rajendran, Anil Vijayakumar Abstract Background: The prevalence of diabetes
More informationExceptional People. Exceptional Care. Antenatal Appointment Schedule for Normal Healthy Women with Singleton Pregnancies
Exceptional People. Exceptional Care. Antenatal Appointment Schedule for Normal Healthy Women with Singleton Pregnancies First Antenatal Contact with the GP Obtain medical and obstetric history. Measure
More informationPreimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
More information23. TERATOGENS AND THEIR EFFECTS
23. TERATOGENS AND THEIR EFFECTS Wendy Chung, M.D. Ph.D. Telephone: 851-5313 e-mail: wkc15@columbia.edu SUMMARY A congenital malformation is an anatomical or structural abnormality present at birth. Congenital
More informationComparison of oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion
Indian J Med Res 122, August 2005, pp 132-136 Comparison of oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion Suneeta Mittal, Sonika Agarwal,
More informationKey words: Homocysteine, Preeclampsia, Vitamin B12, Folic acid
Research Article Effect of Homocysteine,Vitamin B12, Folic acid during pregnancy Arpita P. Patel, Chandan Chakrabarti *, Arjun Singh, Jatin D Patel, Hitesh A.Mewada, S.L.Sharma * Department of Biochemistry,
More informationNutrient Reference Values for Australia and New Zealand
Nutrient Reference Values for Australia and New Zealand Questions and Answers 1. What are Nutrient Reference Values? The Nutrient Reference Values outline the levels of intake of essential nutrients considered,
More informationBlood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.
Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.
More informationFolic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage 1 3
Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage 1 3 Lynn B Bailey and Robert J Berry ABSTRACT Key research findings relative
More information, hereby agree to a form of treatment known
Patient Consent for Therapy Human In Vitro Fertilization and Embryo Transfer This is to certify that I, as In Vitro Fertilization and Embryo Transfer., hereby agree to a form of treatment known I have
More informationKEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.
KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationGuideline Statement for the Treatment of Disseminated Intravascular Coagulation
Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Introduction Though a rare occurrence in the perioperative setting, disseminated intravascular coagulation (DIC) is a syndrome
More informationObjectives. What is undernutrition? What is undernutrition? What does undernutrition look like?
Objectives Basics Jean-Pierre Habicht, MD, PhD Professor Division of Nutritional Sciences Cornell University Types and causes Determinants Consequences Global occurrence and progress Way forward What is
More informationArtificial insemination
Artificial insemination What is involved? Artificial insemination is an assisted reproduction technique that consists of inserting laboratory-treated spermatozoa into the woman s uterus or cervical canal.
More informationFAMILY PLANNING AND PREGNANCY
FAMILY PLANNING AND PREGNANCY Decisions about family planning can be difficult and very emotional when one of the prospective parents has a genetic disorder, such as Marfan syndrome. Before making any
More informationCauses, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
More information